Coercion in the Recruitment and Retention of Human Research Subjects, Pharmaceutical Industry Payments to Physician-Investigators and the Moral Courage of the IRB

IRB: Ethics & Human Research 22 (2):1 (2000)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.2307/3563568

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Payments to Normal Healthy Volunteers in Phase 1 Trials: Avoiding Undue Influence While Distributing Fairly the Burdens of Research Participation.A. S. Iltis - 2009 - Journal of Medicine and Philosophy 34 (1):68-90.
Healthy children as subjects in pharmaceutical research.Gideon Koren - 2003 - Theoretical Medicine and Bioethics 24 (2):149-159.
Understanding physician-pharmaceutical industry interactions.Shaili Jain - 2007 - New York: Cambridge University Press.
Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study. [REVIEW]Susan L. Norris, Haley K. Holmer, Lauren A. Ogden, Brittany U. Burda & Rongwei Fu - 2012 - BMC Medical Ethics 13 (1):24-.
Institutional mistrust in the organization of pharmaceutical clinical trials.Jill A. Fisher - 2008 - Medicine, Health Care and Philosophy 11 (4):403-413.
Clarifying confusions about coercion.Jennifer Susan Hawkins & Ezekiel J. Emanuel - 2005 - Hastings Center Report 35 (5):16-19.
The physician's role in the protection of human research subjects.Professor John R. Williams - 2006 - Science and Engineering Ethics 12 (1):5-12.
Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society.James M. Huebner - 2014 - Journal of Buisness Ethics (3):1-10.
Compensation for subjects of medical research: the moral rights of patients and the power of research ethics committees.S. Guest - 1997 - Journal of Medical Ethics 23 (3):181-185.
Money, coercion, and undue inducement: attitudes about payments to research participants.E. A. Largent, C. Grady, F. G. Miller & A. Wertheimer - 2012 - IRB: Ethics & Human Research 34 (1):1-8.
Dangerous Medicine: The Pharmaceutical Industry's Questionable Ethical Practices.John T. Fielding - unknown
Brightening Up: The Effect of the Physician Payment Sunshine Act on Existing Regulation of Pharmaceutical Marketing.Igor Gorlach & Genevieve Pham-Kanter - 2013 - Journal of Law, Medicine and Ethics 41 (1):315-322.
The connection between academia and industry.Ajai Singh & Shakuntala Singh - 2005 - Mens Sana Monographs 3 (1):5.
.John T. Fielding - unknown
New Rules for Research with Human Participants?Jessica Berg & Nicole Deming - 2011 - Hastings Center Report 41 (6):10-11.

Analytics

Added to PP
2014-03-21

Downloads
36 (#421,132)

6 months
6 (#431,022)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Currents in Contemporary Ethics.Timothy Caulfield & Glenn Griener - 2002 - Journal of Law, Medicine and Ethics 30 (2):305-308.
Currents in Contemporary Ethics.Timothy Caulfield, Trudo Lemmens, Douglas Kinsella & Michael McDonald - 2004 - Journal of Law, Medicine and Ethics 32 (2):365-368.

Add more citations

References found in this work

No references found.

Add more references